Derek Yuan

Derek Yuan, Ph.D. serves as the Managing Director at LYFE Capital since 2018 and holds various board positions, including Board Observer at CytoTronics and Aspen Neuroscience, Inc., as well as Board Member at iECURE, Inc. and formerly at Tempest Therapeutics. With a background in biotech equity research at Credit Suisse and consulting at L.E.K. Consulting, Derek Yuan possesses extensive experience in the life sciences industry. Educational credentials include a Doctor of Philosophy in Biology from The Rockefeller University and a Bachelor of Science in Chemistry and Biology from Tsinghua University.